<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1665-1146</journal-id>
<journal-title><![CDATA[Boletín médico del Hospital Infantil de México]]></journal-title>
<abbrev-journal-title><![CDATA[Bol. Med. Hosp. Infant. Mex.]]></abbrev-journal-title>
<issn>1665-1146</issn>
<publisher>
<publisher-name><![CDATA[Instituto Nacional de Salud, Hospital Infantil de México Federico Gómez]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1665-11462014000200003</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Evaluation of the quality of care of neonates with necrotizing enterocolitis affiliated with Seguro Popular in Mexico]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Pérez-Cuevas]]></surname>
<given-names><![CDATA[Ricardo]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vladislavovna Doubova]]></surname>
<given-names><![CDATA[Svetlana]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jasso-Gutiérrez]]></surname>
<given-names><![CDATA[Luis]]></given-names>
</name>
<xref ref-type="aff" rid="A03"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Flores-Hernández]]></surname>
<given-names><![CDATA[Sergio]]></given-names>
</name>
<xref ref-type="aff" rid="A04"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[O'Shea Cuevas]]></surname>
<given-names><![CDATA[Gabriel]]></given-names>
</name>
<xref ref-type="aff" rid="A05"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Aranza-Doniz]]></surname>
<given-names><![CDATA[Carlos]]></given-names>
</name>
<xref ref-type="aff" rid="A05"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González-Guerra]]></surname>
<given-names><![CDATA[Eduardo]]></given-names>
</name>
<xref ref-type="aff" rid="A06"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Muñoz-Hernández]]></surname>
<given-names><![CDATA[Onofre]]></given-names>
</name>
<xref ref-type="aff" rid="A07"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Banco Interamericano de Desarrollo División de Protección Social y Salud ]]></institution>
<addr-line><![CDATA[Mexico ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="A02">
<institution><![CDATA[,Instituto Mexicano del Seguro Social Centro Médico Nacional Siglo XXI Unidad de Investigación Epidemiológica y en Servicios de Salud]]></institution>
<addr-line><![CDATA[Mexico ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="A03">
<institution><![CDATA[,Secretaría de Salud Hospital Infantil de México Federico Gómez Departamento de Evaluación y Análisis de Medicamentos]]></institution>
<addr-line><![CDATA[Mexico ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="A04">
<institution><![CDATA[,Secretaría de Salud Instituto Nacional de Salud Pública Centro de Investigación en Salud Poblacional]]></institution>
<addr-line><![CDATA[Mexico ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="A05">
<institution><![CDATA[,Secretaría de Salud Comisión Nacional de Protección Social en Salud ]]></institution>
<addr-line><![CDATA[Mexico ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="A06">
<institution><![CDATA[,Universidad Nacional Autónoma de México Facultad de Medicina Departamento de Salud Pública]]></institution>
<addr-line><![CDATA[Mexico ]]></addr-line>
</aff>
<aff id="A07">
<institution><![CDATA[,Secretaría de Salud Hospital Infantil de México Federico Gómez Dirección de Investigación]]></institution>
<addr-line><![CDATA[Mexico ]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2014</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2014</year>
</pub-date>
<volume>71</volume>
<numero>2</numero>
<fpage>76</fpage>
<lpage>82</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1665-11462014000200003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1665-11462014000200003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1665-11462014000200003&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Background: In Mexico there is an important gap of information regarding the quality of care for neonates with necrotizing enterocolitis (NEC). This study aimed at evaluating the quality of care for neonates with NEC affiliated with the program Medical Insurance Century XXI (MIC-XXI), which is a branch of Seguro Popular. Methods: From December 2011 to March 2012, a cross-sectional study took place in 61 hospitals of the Ministry of Health located in 22 Mexican states. A set of 16 quality indicators based on a literature review served for the evaluation. Results: We reviewed 262 medical records of neonates with NEC. More than half were male and born by caesarean section; 55.8% were premature, 55.3% had low birth weight and 12.2% died. Regarding the quality of care, 72.5% were breastfed before being diagnosed with NEC. Most cases had abdominal radiography (90%), 75.0% had diagnosis of NEC according to Bell's criteria, but only 30% had reported symptoms that met the criteria for the recorded stage. Suspension of enteral feeding and administration of antibiotics reached 95.8% and 93.9%, respectively. Twenty six neonates underwent surgery, of which 34% had reported radiographic findings. Conclusion: A wide margin exists to improve the quality of care of neonates with NEC in Mexican Hospitals.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[Necrotizing enterocolitis]]></kwd>
<kwd lng="en"><![CDATA[Care]]></kwd>
<kwd lng="en"><![CDATA[Neonates]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[  	    <p align="justify"><font face="verdana" size="4">Art&iacute;culos de investigaci&oacute;n</font></p>     <p align="justify">&nbsp;</p> 	    <p align="center"><font face="verdana" size="4"><b>Evaluation of the quality of care of neonates with necrotizing enterocolitis affiliated with Seguro Popular in Mexico</b></font></p> 	    <p align="center">&nbsp;</p>      <p align="center"><b><font face="verdana" size="2">Ricardo P&eacute;rez&#45;Cuevas<sup>a</sup>, Svetlana Vladislavovna Doubova<sup>b</sup>, Luis Jasso&#45;Guti&eacute;rrez<sup>c</sup>*, Sergio Flores&#45;Hern&aacute;ndez<sup>d</sup>, Gabriel O'Shea Cuevas<sup>e</sup>, Carlos Aranza&#45;Doniz<sup>e</sup>, Eduardo Gonz&aacute;lez&#45;Guerra<sup>f</sup>, Onofre Mu&ntilde;oz&#45;Hern&aacute;ndez<sup>g</sup></font></b><font face="verdana" size="2"></font></p>     <p align="center">&nbsp;</p>      <p align="justify"><font face="verdana" size="2"><sup><i>a</i></sup> <i>Divisi&oacute;n de Protecci&oacute;n Social y Salud, Banco Interamericano de Desarrollo, Mexico City, Mexico.</i></font></p>        <p align="justify"><i><font face="verdana" size="2"><sup>b</sup> Unidad de Investigaci&oacute;n Epidemiol&oacute;gica y en Servicios de Salud, Centro M&eacute;dico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico City, Mexico.</font></i></p>       <p align="justify"><i><font face="verdana" size="2"><sup>c</sup> Departamento de Evaluaci&oacute;n y An&aacute;lisis de Medicamentos, Hospital Infantil de M&eacute;xico Federico G&oacute;mez, Secretar&iacute;a de Salud, Mexico City, Mexico.</font></i></p>       ]]></body>
<body><![CDATA[<p align="justify"><i><font face="verdana" size="2"><sup>d</sup> Centro de Investigaci&oacute;n en Salud Poblacional, Instituto Nacional de Salud P&uacute;blica, Secretar&iacute;a de Salud, Mexico City, Mexico.</font></i></p>       <p align="justify"><i><font face="verdana" size="2"><sup>e</sup> Comisi&oacute;n Nacional de Protecci&oacute;n Social en Salud, Secretar&iacute;a de Salud, Mexico City, Mexico.</font></i></p>     <p align="justify"><i><font face="verdana" size="2"><sup>f</sup> Departamento de Salud P&uacute;blica, Facultad de Medicina, Universidad Nacional Aut&oacute;noma de M&eacute;xico, Mexico City, Mexico.</font></i></p>     <p align="justify"><i><font face="verdana" size="2"><sup>g </sup> Direcci&oacute;n de Investigaci&oacute;n, Hospital Infantil de M&eacute;xico Federico G&oacute;mez, Secretar&iacute;a de Salud, Mexico City, Mexico.</font></i></p>     <p align="justify">&nbsp;</p>     <p align="justify"><font face="verdana" size="2"><b>* Corresponding author:</b>    <br>   <i>L. Jasso&#45;Guti&eacute;rrez.</i>    <br> E&#45;mail: <a href="mailto:ljasso@himfg.edu.mx">ljasso@himfg.edu.mx</a>.</font></p>     <p align="justify">&nbsp;</p>     <p align="justify"><font size="2" face="verdana">Recived 11 December 2013;    ]]></body>
<body><![CDATA[<br>   Accepted 12 December 2013. </font></p>     <p align="justify">&nbsp;</p>      <p align="justify"><font face="verdana" size="2"><b>Abstract </b></font></p>     <p align="justify"><font face="verdana" size="2"><i>Background:</i> In Mexico there is an important gap of information regarding the quality of care for neonates with necrotizing enterocolitis (NEC). This study aimed at evaluating the quality of care for neonates with NEC affiliated with the program Medical Insurance Century XXI (MIC&#45;XXI), which is a branch of Seguro Popular.</font></p>      <p align="justify"><font face="verdana" size="2"><i>Methods:</i> From December 2011 to March 2012, a cross&#45;sectional study took place in 61 hospitals of the Ministry of Health located in 22 Mexican states. A set of 16 quality indicators based on a literature review served for the evaluation.</font></p>  	    <p align="justify"><font face="verdana" size="2"><i>Results:</i> We reviewed 262 medical records of neonates with NEC. More than half were male and born by caesarean section; 55.8% were premature, 55.3% had low birth weight and 12.2% died. Regarding the quality of care, 72.5% were breastfed before being diagnosed with NEC. Most cases had abdominal radiography (90%), 75.0% had diagnosis of NEC according to Bell's criteria, but only 30% had reported symptoms that met the criteria for the recorded stage. Suspension of enteral feeding and administration of antibiotics reached 95.8% and 93.9%, respectively. Twenty six neonates underwent surgery, of which 34% had reported radiographic findings.</font></p>  	    <p align="justify"><font face="verdana" size="2"><i>Conclusion:</i> A wide margin exists to improve the quality of care of neonates with NEC in Mexican Hospitals.</font></p>     <p align="justify"><font face="verdana" size="2"><b>Keywords:</b> Necrotizing enterocolitis; Care; Neonates.</font></p>     <p>&nbsp;</p>     <p align="justify"><font face="verdana" size="2"><b>1. Introduction</b></font></p>  	    ]]></body>
<body><![CDATA[<p align="justify"><font face="verdana" size="2">Necrotizing enterocolitis (NEC) is an acute gastrointestinal disease that occurs during the neonatal period and is a common cause of admission to neonatal intensive care units (NICU). This disease comprises intestinal necrosis and multiple organ failure. Ninety percent of neonates with NEC are premature. Almost 12% of infants born weighing &lt;1500 g will develop NEC; among those, about 30% will not survive.<sup>1</sup> Near&#45;term and full&#45;term infants also develop the disease. The worldwide prevalence rate of NEC among premature babies ranges from 0.3 to 2.4 per 1000 live births (LB), whereas it is 0.05 per 1000 LB among term neonates. Mortality rate due to NEC is 12.4 deaths per 100,000 LB.<sup>2</sup></font></p>  	    <p align="justify"><font face="verdana" size="2">There is a different pattern of risk factors between NEC in premature and full&#45;term infants. The main risk factors for NEC are prematurity, feeding the neonate with formula, intestinal ischemia, red cell transfusions and intestinal colonization by pathological bacteria.<sup>3,4</sup> In newborns after 35 weeks' gestation the main risk factors are low Apgar scores, birth asphyxia, sepsis, or congenital cardiac or gastrointestinal anomalies.<sup>5</sup> In late&#45;term infants, the risk factors associated with NEC are early&#45;onset sepsis, drug exposure, respiratory distress and being fed only with formula.<sup>6</sup></font></p>  	    <p align="justify"><font face="verdana" size="2">There are several primary prevention strategies for NEC that include administration of corticoids to the mother during labor before preterm delivery. For preterm neonates the recommendations comprise feeding with human milk, liquid restriction and use of probiotics.<sup>7</sup></font></p>  	    <p align="justify"><font face="verdana" size="2">Most NEC cases receive pharmacological treatment in neonatal intensive care units and between 20% and 40% require surgical treatment. However, up to 50% of those who undergo surgery may die due to complications. Once the diagnosis has being made, two thirds of NEC deaths happen with the first 7 days (mean 1 day). The main risk factors for death due to NEC are low gestational age, low birth weight, treatment with assisted ventilation and use of vasopressors at the time of diagnosis.<sup>8</sup></font></p>  	    <p align="justify"><font face="verdana" size="2">Despite the progress in the neonatal care arena, prevalence of NEC has not decreased. This in part is due to the increase in the survival rate of very low birth weight premature neonates. These circumstances point out the importance of the provision of effective preventive care such as the implementation of feeding guidelines and availability and use of human milk<sup>9</sup> along with medical and surgical treatment that must be congruent with current best medical practices.<sup>10,11</sup></font></p>  	    <p align="justify"><font face="verdana" size="2">The Mexican government has in place different policies and programs to provide healthcare to infants and newborns. In December 2006, Seguro Popular launched the noncontributory health insurance program "Medical Insurance for the New Generation" that, in 2013, was renamed as Medical Insurance Century XXI (MIC&#45;XXI). MIC&#45;XXI aims at improving access and contributing to decrease impoverishment due to health causes through universal insurance for all children born after December 2006 who are not affiliated with a social security institution.<sup>12</sup> Currently, six million children are affiliated with this program.<sup>13</sup></font></p>  	    <p align="justify"><font face="verdana" size="2">MIC&#45;XXI finances the treatment of NEC among several other conditions of neonates who receive care in hospitals affiliated with the Ministry of Health (MoH). These hospitals must be certified before being able to receive funds to provide healthcare to MIC&#45;XXI beneficiaries. The certification implies that the hospital must have appropriately trained health personnel, availability of equipment, and having neonatal intensive care units. Nonetheless, the certification is a snapshot of the capability of the hospitals and there are no routine evaluations of the quality of care that these hospitals provide; in fact, the practice of evaluating the quality of care is incipient in pediatric hospitals in the country and has not been fully institutionalized.<sup>14</sup></font></p>  	    <p align="justify"><font face="verdana" size="2">In Mexico, little is known about the current prevalence and mortality rates of neonates with NEC admitted to NICUs and no formal studies have been conducted to evaluate the quality of care for this condition. Lack of proper health information systems and of quality of care indicators along with a poorly developed culture of evaluation contribute to these circumstances. To bridge the gaps of clinical information regarding NEC care in Mexican hospitals, the main objective of this study was to evaluate the quality of care that neonates with NEC receive in hospitals affiliated with MIC&#45;XXI.</font></p>     <p align="justify">&nbsp;</p>      <p align="justify"><font face="verdana" size="2"><b>2. Methods</b></font></p>  	    ]]></body>
<body><![CDATA[<p align="justify"><font face="verdana" size="2">From December 2011 to March 2012, a cross&#45;sectional study took place in 61 hospitals of the MoH located in 22 Mexican states. All these hospitals must have affiliation with the MIC&#45;XXI and provide medical care to at least two NEC cases in the first semester of 2011. During that year, 505 neonates were admitted with diagnosis of NEC, of whom 11.9% died. The sampling design considered the total number of NEC cases who received care in these hospitals, from which a random sample of recently discharged cases was selected. It was decided to select up to four cases per hospital.</font></p>  	    <p align="justify"><font face="verdana" size="2">The variables of the study were the following:</font></p>  	    <p align="justify"><font face="verdana" size="2"><i>Characteristics of the mothers</i>&#45;age, marital status, occupation (housewife or work outside the house), gravidity (nulliparous or multigravida), pre&#45;existing chronic diseases and history of antenatal care that included attendance at MoH facilities, initiation of antenatal care during the first trimester of gestation and pregnancy complications.</font></p>  	    <p align="justify"><font face="verdana" size="2"><i>Characteristics of the neonates with NEC</i>&#45;sex, gestational age (immature (&lt;28 weeks), premature (28&#45;37 weeks), term (&gt;37 and &le;41), post&#45;term (&ge;42 weeks) and birth weight. <i>Type of delivery and characteristics of the hospital care</i>&#45; type of delivery (vaginal delivery, cesarean section), characteristics of the referral to the neonatal intensive care unit, length of stay and comorbidity.</font></p>  	    <p align="justify"><font face="verdana" size="2"><i>Severity of the neonatal disease measured through the Neonatal Therapeutic Intervention Scoring System (NTISS)</i><sup>15</sup>&#45;The NTISS takes into account the therapeutic intensity and complexity to score the severity of the condition. It is based on the assumption that the treatment intensity correlates directly with the severity of disease. NTISS score is computed as the arithmetic sum of therapy points received by the neonate in a 24&#45;h period, ranging from 0 to 47. The highest score means greater treatment intensity and, consequently, more severity of the neonate. The total NTISS score is the sum of eight subscores (respiratory, cardiovascular, drug therapy, monitoring, metabolic/ nutrition, transfusion, procedural and vascular access). The conditions of the neonate at hospital discharge were also documented.</font></p>  	    <p align="justify"><font face="verdana" size="2"><i>Quality of care</i>&#45;A set of quality indicators served to evaluate the quality of NEC care. Three pediatricians, including one neonatologist, conducted the review of the literature and developed the set of 16 indicators. The review comprised clinical guidelines, systematic reviews and the protocol that MIC&#45;XXI issued for NEC care. To propose the quality of care indicators, the literature was examined in terms of its scientific validity and local feasibility. The indicators addressed three fields: prevention, diagnostic procedures and treatment.</font></p>  	    <blockquote> 	      <p align="justify"><font face="verdana" size="2">&bull; Prevention focused on neonates who, after delivery and before the diagnosis of NEC, were fed with breast milk.</font></p> 	      <p align="justify"><font face="verdana" size="2">&bull; Diagnostic procedures performed such as abdominal radiography, complete blood count, serum electrolytes, blood cultures arterial blood gas, fecal occult blood, urinalysis, cytochemical and CSF culture. The Bell scale was used to diagnose and classify neonates with NEC.</font></p> 	      <p align="justify"><font face="verdana" size="2">&bull; Treatment criteria included discontinuation of enteral feeding, placement of orogastric tube, administration of broad&#45;spectrum antibiotics for gram positive and negative bacteria when diagnosis of NEC was made, neonates who underwent surgery with radiographic evidence of free air in radiography and neonates in whom after 14 days of absence of any radiographic abnormality, enteral feeding was restarted.</font></p> </blockquote>     ]]></body>
<body><![CDATA[<p align="justify"><font face="verdana" size="2"><b>2.1. Data collection method</b></font></p>  	    <p align="justify"><font face="verdana" size="2">Previously trained pediatricians gathered the information directly from the clinical records in a data collection instrument developed ad hoc. All the information was registered in a database. The Commission of Ethics and Research of Hospital Infantil de Mexico Federico Gomez authorized the study protocol.</font></p>     <p align="justify"><font face="verdana" size="2"><b>2.2. Statistical analysis</b></font></p>  	    <p align="justify"><font face="verdana" size="2">The information was analyzed using descriptive statistics. The analysis was performed using the statistical package Stata 8.0 (Stata 8.0, Stata Corp., College Station, TX).</font></p> 	    <p align="justify">&nbsp;</p>     <p align="justify"><font face="verdana" size="2"><b>3. Results</b></font></p>  	    <p align="justify"><font face="verdana" size="2">The study included 262 medical records of neonates diagnosed with NEC who were treated in neonatal intensive care units (NICU) of 61 MoH hospitals. <a href="#t1">Table 1</a> presents the characteristics of the mothers of these neonates; the median age was 23.5 years, most were single or divorced, and 80.9% were housewives. One third were nulliparous and most had received antenatal care in MoH facilities; less than half began antenatal care during the first trimester of gestation and almost 50% had pregnancy complications.</font></p>  	    <p align="center"><a name="t1"></a><img src="/img/revistas/bmim/v71n2/a3t1.jpg"></p>      <p align="justify"><font face="verdana" size="2"><a href="#t2">Table 2</a> shows the characteristics of the neonates. More than half of neonates were male and born by caesarean section; 55.8% were premature, 55.3% had low birth weight, and 17.9% weighted &le;1500 g. Most neonates with NEC were admitted to the NICU of the hospital where they were delivered; whereas 27% were transferred from another hospital, 60% were transferred by ambulance, 40% in incubator and 12% required mechanical ventilation during transportation. On average, the length of stay of a neonate with NEC was 24 days (range: 1&#45;92 days. Regarding the health outcomes, most showed clinical improvement; however, 12.2% died and 2% had incomplete data.</font></p>  	    <p align="center"><a name="t2"></a><img src="/img/revistas/bmim/v71n2/a3t2.jpg"></p>      ]]></body>
<body><![CDATA[<p align="justify"><font face="verdana" size="2"><a href="#t3">Table 3</a> describes the comorbidity and severity of neonates with NEC during the hospital stay. The most frequent comorbidities were infections (50.4%), hematologic complications (14.9%) and intracranial hemorrhage (8.4%). On average, the NTISS total score was 20.4 points.</font></p>  	    <p align="center"><a name="t3"></a><img src="/img/revistas/bmim/v71n2/a3t3.jpg"></p>      <p align="justify"><font face="verdana" size="2"><a href="#t4">Table 4</a> shows the therapeutic interventions received by newborns according to subscales of NITSS, which included respiratory, cardiovascular, drug therapy, monitoring, metabolic/nutrition, vascular access and transfusion. These interventions are congruent with the clinical conditions and comorbidities of neonates with NEC.</font></p>  	    <p align="center"><a name="t4"></a><img src="/img/revistas/bmim/v71n2/a3t4.jpg"></p>      <p align="justify"><font face="verdana" size="2"><a href="#t5">Table 5</a> presents the results of the quality of care evaluation using the set of indicators. Regarding the prevention component, 72.5% of neonates were fed with breast milk before being diagnosed with NEC. The component of diagnostic procedures showed that most cases had abdominal radiography and complete blood count (90% and 89%, respectively). The less performed tests were cerebrospinal fluid culture, urinalysis and fecal occult blood test; 75.0% of infants had diagnosis of NEC according to the Modifying Bell's staying criteria, but only 30% had reported signs and symptoms that met the criteria for the recorded Bell stage. Regarding the treatment component, the indicators that showed good performance were suspension of enteral feeding and administration of broad&#45;spectrum antibiotics for Gram&#45;positive and Gram&#45;negative bacteria since the diagnosis of NEC was made. Other treatment indicators showed that the orogastric tube was placed in 67%. Of 26 neonates who underwent surgery, only in 34% was the radiographic finding reported and in 45% enteral feeding was restarted after 14 days of absence of any radiographic abnormality.</font></p>  	    <p align="center"><a name="t5"></a><img src="/img/revistas/bmim/v71n2/a3t5.jpg"></p>     <p align="center">&nbsp;</p>      <p align="justify"><font face="verdana" size="2"><b>4. Discussion</b></font></p>  	    <p align="justify"><font face="verdana" size="2">The main findings show that there is a wide margin for improving the quality of care that neonates with NEC receive in Mexican MoH hospitals. The use of a set of indicators to measure QoC allowed identifying some key components in the areas of prevention, diagnostic procedures and treatment that can be improved. The health outcomes of the neonates in this group of hospitals were similar to what the literature reports in terms of mortality due to NEC complications; in the present study 12.2% of NEC cases died.</font></p>  	    <p align="justify"><font face="verdana" size="2">According to the literature, NEC occurs most frequently in preterm neonates with very low birth weight; in our study, 55.5% of neonates were premature and 42% were at term. This finding is consistent with other studies that reported an increased incidence of NEC in children born at term,<sup>16</sup> especially among neonates admitted to the NICUs for conditions other than NEC such as congenital heart disease, polycythemia and bacterial sepsis, among others.<sup>17</sup> Furthermore, most NEC neonates had comorbidities, primarily hematologic complications and infections.</font></p>  	    ]]></body>
<body><![CDATA[<p align="justify"><font face="verdana" size="2">The NTISS score reached on average 20 points. This finding depicts that neonates with NEC in the present study were at moderate to severe conditions. A previous study that validated NTISS in neonates hospitalized in NICUs in the U.S. reported an average score of 12. That study found that high NTISS score was associated with increased risk of death, longer length of stay and high costs of care.</font></p>  	    <p align="justify"><font face="verdana" size="2">Treatment for NEC is determined by local practices including the training of medical doctors and availability of supplies and equipment in the NICUs. In the Mexican health sector context this represents a wide variability that should be considered to perform evaluations or set standards. It is worth mentioning that the average length of stay in the present study was 24 days, which is less than the average length of stay of 49 days that has been reported in the U.S.<sup>18</sup> Studies in other countries have found that the quality of care in NICUs is variable among hospitals,<sup>19&#45;21</sup> and that high quality care consistent with scientific evidence is linked with better health outcomes which, in turn, contribute to reduce mortality in this age group.</font></p>  	    <p align="justify"><font face="verdana" size="2">Measuring quality requires instruments that are valid and feasible. The proposed indicators may be the groundwork in the development of quality of care indicators for neonates with NEC in Mexican hospitals. It is worth completing its validation through a robust method such as the RAND&#45;UCLA<sup>22</sup> method that combines systematic literature review and a process that scores the validity and feasibility of the indicators by an expert group. According to the RAND&#45;UCLA validation method, the indicator should assume that those healthcare professionals who deliver the services close to the indicator provide better quality than those who do not. In addition, an indicator is considered feasible when there is a high probability that the information for it was available in a typical clinical record. Indeed, if such information was missing, this would signal poor quality of care. For example, according to the literature, one of the indicators important for the prevention of NEC is the indication of probiotics to preterm infants; however, in the MoH hospitals probiotics are not available; thus, this indicator is not feasible. It is advisable for the MoH to consider the possibility of introducing probiotics, given the evidence of its preventive effect. A meta&#45;analysis of 16 controlled clinical trials, which included 2842 preterm infants, found that enteral probiotic supplementation significantly reduces the incidence of severe NEC (stage II or higher) (RR 0.35, 95% CI, 24&#45;0, 52 95) and mortality (RR 0.40, 95% CI 0.27, 0.60).<sup>23</sup></font></p>  	    <p align="justify"><font face="verdana" size="2">It was not possible to assess whether antenatal steroids were given during preterm delivery because this information is not routinely registered in the NICU records, but in the mothers' clinical records. Administration of antenatal steroids aims at decreasing the risk of respiratory distress syndrome and this condition is associated with increased risk of NEC. From this perspective, it is crucial to develop effective strategies of continuous care with a preventive approach for premature neonates which includes, among others, strategies to improve data recording, e.g., use of prenatal steroids. Unfortunately, most MoH hospitals do not have electronic health records and the information was gathered from paper records. Lack of continuity in the management and registration of clinical information is an important gap to run routine evaluations of the quality of care.</font></p>  	    <p align="justify"><font face="verdana" size="2">The quality of care of NEC at MoH hospitals in Mexico requires improvements in all areas of the process of care: prevention, diagnosis and treatment. Although most neonates received human milk before being diagnosed with NEC, there are no explicit feeding guidelines. The current rules of operation of MIC&#45;XXI comprise an important investment in milk banks in several hospitals of the MoH. The availability of human milk, along with the implementation of feeding guidelines, would help to decrease the severity and mortality of NEC.</font></p>  	    <p align="justify"><font face="verdana" size="2">The protocol that MIC&#45;XXI issued for NEC care<sup>24</sup> indicates that its treatment should be performed according to the Bell registered stage, which is a worldwide recommended criterion; nevertheless, a third of the neonates did not have the diagnosis based on this classification. Furthermore, only 30% of medical records had symptoms and signs that met the Bell criteria. This finding is worrisome given that this could translate to some deficiencies in the treatment of 70% of the neonates.</font></p>  	    <p align="justify"><font face="verdana" size="2">In this study, 20% of neonates required surgical treatment, which gives us an idea of the potential for complications in these children and the resources it implies. This figure is congruent with the assumption that between 20 and 40% of neonates with NEC would require surgical treatment. However, it was noticeable that one third of the neonates who underwent surgical treatment did not have a record of radiographic finding (presence of air) to justify the surgical procedure.</font></p>  	    <p align="justify"><font face="verdana" size="2">Among the study limitations, it is relevant to mention that the results are not generalizable to all health institutions in Mexico. The study was focused on MoH hospitals that were providing care to MIC&#45;XXI affiliates. Also, the indicators should be validated with further rigor; the fact that these neonates had different comorbid conditions makes it more difficult to define generalizable indicators. The methodology used in this study can be replicated to evaluate and compare the quality of care in other hospitals in Mexico and other countries.</font></p>  	    <p align="justify"><font face="verdana" size="2">The evaluation of the quality of care for neonates with NEC in MoH hospitals indicates that there is wide margin for improvement. It is advisable to strengthen the implementation of clinical practice guidelines for NEC at NICUS, but also to facilitate the institutionalization of the evaluation of the quality of care in Mexican public hospitals.</font></p>     <p align="justify">&nbsp;</p>      ]]></body>
<body><![CDATA[<p align="justify"><font face="verdana" size="2"><b>Conflict of interest</b></font></p>  	    <p align="justify"><font face="verdana" size="2">The authors declare no conflict of interest of any nature.</font></p> 	    <p align="justify">&nbsp;</p>     <p align="justify"><font face="verdana" size="2"><b>REFERENCES</b></font></p>  	    <!-- ref --><p align="justify"><font face="verdana" size="2">1. Gephart S, McGrath JM, Effken JA, Halpern MD. Necrotizing enterocolitis risk: state of the science. Adv Neonatal Care.  2012; 12:77&#45;89.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559574&pid=S1665-1146201400020000300001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>  	    <!-- ref --><p align="justify"><font face="verdana" size="2">2. Pellegrini M, Lagrasta N, Garc&iacute;a&#45;Garc&iacute;a C, Campos Serna J, Zicari E, Marzocca G. Neonatal necrotizing enterocolitis: a focus on. Eur Rev Med Pharmacol Sci.  2002; 6:19&#45;25.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559576&pid=S1665-1146201400020000300002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>  	    <!-- ref --><p align="justify"><font face="verdana" size="2">3. Yeo SL. NICU update: state of the science of NEC. J Perinat Neonatal Nurs.  2006; 20:46&#45;50.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559578&pid=S1665-1146201400020000300003&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>  	    ]]></body>
<body><![CDATA[<!-- ref --><p align="justify"><font face="verdana" size="2">4. Amin SC, Remon JI, Subbarao GC, Maheshwari A. Association between red cell transfusions and necrotizing enterocolitis. J Matern Fetal Neonatal Med.  2012; 25(suppl 5):85&#45;9.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559580&pid=S1665-1146201400020000300004&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>      <!-- ref --><p align="justify"><font face="verdana" size="2">5. McElhinney DB, Hedrick HL, Bush DM, Pereira GR, Stafford PW, Gaynor JW, et al. Necrotizing enterocolitis in neonates with congenital heart disease: risk factors and outcomes. Pediatrics.  2000; 106:1080&#45;7.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559582&pid=S1665-1146201400020000300005&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>  	    <!-- ref --><p align="justify"><font face="verdana" size="2">6. Stout G, Lambert DK, Baer VL, Gordon PV, Henry E, Wiedmeier SE, et al. Necrotizing enterocolitis during the first week of life: a multicentered case&#45;control and cohort comparison study. J Perinatol.  2008; 28:556&#45;60.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559584&pid=S1665-1146201400020000300006&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>  	    <!-- ref --><p align="justify"><font face="verdana" size="2">7. Lin HY, Chang JH, Chung MY, Lin HC. Prevention of necrotizing enterocolitis in preterm very low birth weight infants: is it feasible? J Formos Med Assoc. 2013. pii: S0929&#45;6646(13)00126&#45;5. doi:10.1016/j.jfma.2013.03.010.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559586&pid=S1665-1146201400020000300007&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>  	    <!-- ref --><p align="justify"><font face="verdana" size="2">8. Clark RH, Gordon P, Walker WM, Laughon M, Smith PB, Spitzer AR. Characteristics of patients who die of necrotizing enterocolitis. J Perinatol.  2012; 32:199&#45;204.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559588&pid=S1665-1146201400020000300008&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>  	    ]]></body>
<body><![CDATA[<!-- ref --><p align="justify"><font face="verdana" size="2">9. Sullivan S, Schanler RJ, Kim JH, Patel AL, Traw&ouml;ger R, Kiech&#45;Kohlendorfer U, et al. An exclusively human milk&#45;based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk&#45;based products. J Pediatr. 2010; 156:562&#45;7.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559590&pid=S1665-1146201400020000300009&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>  	    <!-- ref --><p align="justify"><font face="verdana" size="2">10. Thompson AM, Bizzarro MJ. Necrotizing enterocolitis in newborns: pathogenesis, prevention and management. Drugs.  2008; 68:1227&#45;38.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559592&pid=S1665-1146201400020000300010&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>  	    <!-- ref --><p align="justify"><font face="verdana" size="2">11. Gregory KE, DeForge CE, Natale KM, Phillips M, Van Marter LJ. Necrotizing enterocolitis in the premature infant: neonatal nursing assessment, disease pathogenesis, and clinical presentation. Adv Neonatal Care.  2011; 11:155&#45;64.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559594&pid=S1665-1146201400020000300011&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>  	    <!-- ref --><p align="justify"><font face="verdana" size="2">12. Mu&ntilde;oz&#45;Hern&aacute;ndez O, Chertorivski&#45;Woldenberg S, Cort&eacute;s&#45;Gallo G, P&eacute;rez&#45;Cuevas R. The Medical Insurance for a New Generation: a viable answer for the health needs of Mexican children. Salud Publica Mex.  2012; 54(suppl 1):S3&#45;S10.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559596&pid=S1665-1146201400020000300012&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>  	    <!-- ref --><p align="justify"><font face="verdana" size="2">13. Secretar&iacute;a de Salud. Sistema de Protecci&oacute;n Social en Salud. Informe de Resultados, January&#45;June 2013. p. 25. Available from: <a href="http://www.seguro&#45;popular.salud.gob.mx/images/pdf/informes/Informe&#45;de&#45;Resultados&#45;del&#45;SPSS&#45;Enero&#45;Junio%202013.pdf" target="_blank">http://www.seguro&#45;popular.salud.gob.mx/images/pdf/informes/Informe&#45;de&#45;Resultados&#45;del&#45;SPSS&#45;Enero&#45;Junio%202013.pdf</a>.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559598&pid=S1665-1146201400020000300013&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>      ]]></body>
<body><![CDATA[<!-- ref --><p align="justify"><font face="verdana" size="2">14. Jasso&#45;Guti&eacute;rrez L, Dur&aacute;n&#45;Arenas L, Flores&#45;Huerta S, Cort&eacute;s&#45;Gallo G. Recommendations to improve healthcare of neonates with respiratory insufficiency beneficiaries of Seguro Popular. Salud Publica Mex.  2012; 54(suppl 1):S57&#45;64.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559600&pid=S1665-1146201400020000300014&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>  	    <!-- ref --><p align="justify"><font face="verdana" size="2">15. Gray JE, Richardson DK, McCormick MC, Workman&#45;Daniels K, Goldmann DA. Neonatal therapeutic intervention scoring system: a therapy&#45;based severity&#45;of&#45;illness index. Pediatrics.  1992; 90:561&#45;7.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559602&pid=S1665-1146201400020000300015&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>  	    <!-- ref --><p align="justify"><font face="verdana" size="2">16. Maayan&#45;Metzger A, Itzchak A, Mazkereth R, Kuint J. Necrotizing enterocolitis in full&#45;term infants: case&#45;control study and review of the literature. J Perinatol.  2004; 24:494&#45;9.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559604&pid=S1665-1146201400020000300016&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>  	    <!-- ref --><p align="justify"><font face="verdana" size="2">17. Lambert DK, Christensen RD, Henry E, Besner GE, Baer VL, Wiedmeier SE, et al. Necrotizing enterocolitis in term neonates: data from a multihospital health&#45;care system. J Perinatol.  2007; 27:437&#45;43.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559606&pid=S1665-1146201400020000300017&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>  	    <!-- ref --><p align="justify"><font face="verdana" size="2">18. Bisquera JA, Cooper TR, Berseth CL. Impact of necrotizing enterocolitis on length of stay and hospital charges in very low birth weight infants. Pediatrics.  2002; 109:423&#45;8.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559608&pid=S1665-1146201400020000300018&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>  	    ]]></body>
<body><![CDATA[<!-- ref --><p align="justify"><font face="verdana" size="2">19. Kaplan HC, Lorch SA, Pinto&#45;Martin J, Putt M, Silber JH. Assessment of surfactant use in preterm infants as a marker of neonatal intensive care unit quality. BMC Health Serv Res.  2011; 11:22.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559610&pid=S1665-1146201400020000300019&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>  	    <!-- ref --><p align="justify"><font face="verdana" size="2">20. Kaplan HC, Tabangin ME, McClendon D, Meinzen&#45;Derr J, Margolis PA, Donovan EF. Understanding variation in vitamin A supplementation among NICUs. Pediatrics. 2010; 126:e367&#45;73.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559612&pid=S1665-1146201400020000300020&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>  	    <!-- ref --><p align="justify"><font face="verdana" size="2">21. Synnes AR, Chien LY, Peliowski A, Baboolal R, Lee SK; Canadian NICU Network. Variations in intraventricular hemorrhage incidence rates among Canadian neonatal intensive care units. J Pediatr.  2001; 138:525&#45;31.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559614&pid=S1665-1146201400020000300021&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>  	    <!-- ref --><p align="justify"><font face="verdana" size="2">22. Brook RH, Chassin MR, Fink A, Solomon DH, Kosecoff J, Park RE. A method for the detailed assessment of the appropriateness of medical technologies. Int J Technol Assess Health Care.  1986; 2:53&#45;63.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559616&pid=S1665-1146201400020000300022&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>  	    <!-- ref --><p align="justify"><font face="verdana" size="2">23. Alfaleh K, Anabrees J, Bassler D, Al&#45;Kharfi T. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev. Cochrane Database Syst Rev.  2011; (3): CD005496. doi: 10.1002/14651858CD005496.pub3.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559618&pid=S1665-1146201400020000300023&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>  	    ]]></body>
<body><![CDATA[<!-- ref --><p align="justify"><font face="verdana" size="2">24. Secretar&iacute;a de Salud. Protocolos de Atenci&oacute;n M&eacute;dica. Intervenciones cubiertas por el Programa Seguro M&eacute;dico para una nueva generaci&oacute;n. Secretar&iacute;a de Salud; 2009. Available from: <a href="http://www.saludzac.gob.mx/site/images/stories/SeguroPopular/FormatosPDF/SMNG/protocolosmng2014.pdf" target="_blank">http://www.saludzac.gob.mx/site/images/stories/SeguroPopular/FormatosPDF/SMNG/protocolosmng2014.pdf</a>.    &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=1559620&pid=S1665-1146201400020000300024&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --></font></p>      ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gephart]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[McGrath]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Effken]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Halpern]]></surname>
<given-names><![CDATA[MD]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Necrotizing enterocolitis risk: state of the science]]></article-title>
<source><![CDATA[Adv Neonatal Care]]></source>
<year>2012</year>
<volume>12</volume>
<page-range>77-89</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Pellegrini]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Lagrasta]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[García-García]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Campos Serna]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Zicari]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Marzocca]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Neonatal necrotizing enterocolitis: a focus on]]></article-title>
<source><![CDATA[Eur Rev Med Pharmacol Sci]]></source>
<year>2002</year>
<volume>6</volume>
<page-range>19-25</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Yeo]]></surname>
<given-names><![CDATA[SL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[NICU update: state of the science of NEC]]></article-title>
<source><![CDATA[J Perinat Neonatal Nurs]]></source>
<year>2006</year>
<volume>20</volume>
<page-range>46-50</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Amin]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Remon]]></surname>
<given-names><![CDATA[JI]]></given-names>
</name>
<name>
<surname><![CDATA[Subbarao]]></surname>
<given-names><![CDATA[GC]]></given-names>
</name>
<name>
<surname><![CDATA[Maheshwari]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Association between red cell transfusions and necrotizing enterocolitis]]></article-title>
<source><![CDATA[J Matern Fetal Neonatal Med]]></source>
<year>2012</year>
<page-range>85-9</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[McElhinney]]></surname>
<given-names><![CDATA[DB]]></given-names>
</name>
<name>
<surname><![CDATA[Hedrick]]></surname>
<given-names><![CDATA[HL]]></given-names>
</name>
<name>
<surname><![CDATA[Bush]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Pereira]]></surname>
<given-names><![CDATA[GR]]></given-names>
</name>
<name>
<surname><![CDATA[Stafford]]></surname>
<given-names><![CDATA[PW]]></given-names>
</name>
<name>
<surname><![CDATA[Gaynor]]></surname>
<given-names><![CDATA[JW]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Necrotizing enterocolitis in neonates with congenital heart disease: risk factors and outcomes]]></article-title>
<source><![CDATA[Pediatrics]]></source>
<year>2000</year>
<volume>106</volume>
<page-range>1080-7</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stout]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Lambert]]></surname>
<given-names><![CDATA[DK]]></given-names>
</name>
<name>
<surname><![CDATA[Baer]]></surname>
<given-names><![CDATA[VL]]></given-names>
</name>
<name>
<surname><![CDATA[Gordon]]></surname>
<given-names><![CDATA[PV]]></given-names>
</name>
<name>
<surname><![CDATA[Henry]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Wiedmeier]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Necrotizing enterocolitis during the first week of life: a multicentered case-control and cohort comparison study]]></article-title>
<source><![CDATA[J Perinatol]]></source>
<year>2008</year>
<volume>28</volume>
<page-range>556-60</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[HY]]></given-names>
</name>
<name>
<surname><![CDATA[Chang]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Chung]]></surname>
<given-names><![CDATA[MY]]></given-names>
</name>
<name>
<surname><![CDATA[Lin]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Prevention of necrotizing enterocolitis in preterm very low birth weight infants: is it feasible?]]></article-title>
<source><![CDATA[J Formos Med Assoc]]></source>
<year>2013</year>
<volume>13</volume>
<page-range>S0929-6646</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Clark]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
<name>
<surname><![CDATA[Gordon]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Walker]]></surname>
<given-names><![CDATA[WM]]></given-names>
</name>
<name>
<surname><![CDATA[Laughon]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[PB]]></given-names>
</name>
<name>
<surname><![CDATA[Spitzer]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Characteristics of patients who die of necrotizing enterocolitis]]></article-title>
<source><![CDATA[J Perinatol]]></source>
<year>2012</year>
<volume>32</volume>
<page-range>199-204</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sullivan]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Schanler]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
<name>
<surname><![CDATA[Patel]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Trawöger]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Kiech-Kohlendorfer]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[An exclusively human milk-based diet is associated with a lower rate of necrotizing enterocolitis than a diet of human milk and bovine milk-based products]]></article-title>
<source><![CDATA[J Pediatr]]></source>
<year>2010</year>
<volume>156</volume>
<page-range>562-7</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thompson]]></surname>
<given-names><![CDATA[AM]]></given-names>
</name>
<name>
<surname><![CDATA[Bizzarro]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Necrotizing enterocolitis in newborns: pathogenesis, prevention and management]]></article-title>
<source><![CDATA[Drugs]]></source>
<year>2008</year>
<volume>68</volume>
<page-range>1227-38</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gregory]]></surname>
<given-names><![CDATA[KE]]></given-names>
</name>
<name>
<surname><![CDATA[DeForge]]></surname>
<given-names><![CDATA[CE]]></given-names>
</name>
<name>
<surname><![CDATA[Natale]]></surname>
<given-names><![CDATA[KM]]></given-names>
</name>
<name>
<surname><![CDATA[Phillips]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Van Marter]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Necrotizing enterocolitis in the premature infant: neonatal nursing assessment, disease pathogenesis, and clinical presentation]]></article-title>
<source><![CDATA[Adv Neonatal Care]]></source>
<year>2011</year>
<volume>11</volume>
<page-range>155-64</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Muñoz-Hernández]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Chertorivski-Woldenberg]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Cortés-Gallo]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez-Cuevas]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The Medical Insurance for a New Generation: a viable answer for the health needs of Mexican children]]></article-title>
<source><![CDATA[Salud Publica Mex]]></source>
<year>2012</year>
<volume>54</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>S3-S10</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="">
<collab>Secretaría de Salud^dSistema de Protección Social en Salud</collab>
<source><![CDATA[Informe de Resultados]]></source>
<year>Janu</year>
<month>ar</month>
<day>y-</day>
<page-range>25</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jasso-Gutiérrez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Durán-Arenas]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Flores-Huerta]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Cortés-Gallo]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Recommendations to improve healthcare of neonates with respiratory insufficiency beneficiaries of Seguro Popular]]></article-title>
<source><![CDATA[Salud Publica Mex]]></source>
<year>2012</year>
<volume>54</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>S57-64</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gray]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Richardson]]></surname>
<given-names><![CDATA[DK]]></given-names>
</name>
<name>
<surname><![CDATA[McCormick]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Workman-Daniels]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Goldmann]]></surname>
<given-names><![CDATA[DA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Neonatal therapeutic intervention scoring system: a therapy-based severity-of-illness index]]></article-title>
<source><![CDATA[Pediatrics]]></source>
<year>1992</year>
<volume>90</volume>
<page-range>561-7</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maayan-Metzger]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Itzchak]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Mazkereth]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Kuint]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Necrotizing enterocolitis in full-term infants: case-control study and review of the literature]]></article-title>
<source><![CDATA[J Perinatol]]></source>
<year>2004</year>
<volume>24</volume>
<page-range>494-9</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lambert]]></surname>
<given-names><![CDATA[DK]]></given-names>
</name>
<name>
<surname><![CDATA[Christensen]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
<name>
<surname><![CDATA[Henry]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Besner]]></surname>
<given-names><![CDATA[GE]]></given-names>
</name>
<name>
<surname><![CDATA[Baer]]></surname>
<given-names><![CDATA[VL]]></given-names>
</name>
<name>
<surname><![CDATA[Wiedmeier]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Necrotizing enterocolitis in term neonates: data from a multihospital health-care system]]></article-title>
<source><![CDATA[J Perinatol]]></source>
<year>2007</year>
<volume>27</volume>
<page-range>437-43</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bisquera]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Cooper]]></surname>
<given-names><![CDATA[TR]]></given-names>
</name>
<name>
<surname><![CDATA[Berseth]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Impact of necrotizing enterocolitis on length of stay and hospital charges in very low birth weight infants]]></article-title>
<source><![CDATA[Pediatrics]]></source>
<year>2002</year>
<volume>109</volume>
<page-range>423-8</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kaplan]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
<name>
<surname><![CDATA[Lorch]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Pinto-Martin]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Putt]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Silber]]></surname>
<given-names><![CDATA[JH]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Assessment of surfactant use in preterm infants as a marker of neonatal intensive care unit quality]]></article-title>
<source><![CDATA[BMC Health Serv Res]]></source>
<year>2011</year>
<volume>11</volume>
<page-range>22</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kaplan]]></surname>
<given-names><![CDATA[HC]]></given-names>
</name>
<name>
<surname><![CDATA[Tabangin]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[McClendon]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Meinzen-Derr]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Margolis]]></surname>
<given-names><![CDATA[PA]]></given-names>
</name>
<name>
<surname><![CDATA[Donovan]]></surname>
<given-names><![CDATA[EF]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Understanding variation in vitamin A supplementation among NICUs]]></article-title>
<source><![CDATA[Pediatrics]]></source>
<year>2010</year>
<volume>126</volume>
<page-range>e367-73</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Synnes]]></surname>
<given-names><![CDATA[AR]]></given-names>
</name>
<name>
<surname><![CDATA[Chien]]></surname>
<given-names><![CDATA[LY]]></given-names>
</name>
<name>
<surname><![CDATA[Peliowski]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Baboolal]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Canadian NICU Network. Variations in intraventricular hemorrhage incidence rates among Canadian neonatal intensive care units]]></article-title>
<source><![CDATA[J Pediatr]]></source>
<year>2001</year>
<volume>138</volume>
<page-range>525-31</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Brook]]></surname>
<given-names><![CDATA[RH]]></given-names>
</name>
<name>
<surname><![CDATA[Chassin]]></surname>
<given-names><![CDATA[MR]]></given-names>
</name>
<name>
<surname><![CDATA[Fink]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Solomon]]></surname>
<given-names><![CDATA[DH]]></given-names>
</name>
<name>
<surname><![CDATA[Kosecoff]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[RE]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[A method for the detailed assessment of the appropriateness of medical technologies]]></article-title>
<source><![CDATA[Int J Technol Assess Health Care]]></source>
<year>1986</year>
<volume>2</volume>
<page-range>53-63</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alfaleh]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Anabrees]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Bassler]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Al-Kharfi]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev]]></article-title>
<source><![CDATA[Cochrane Database Syst Rev]]></source>
<year>2011</year>
<volume>3</volume>
<page-range>CD005496</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="book">
<collab>Secretaría de Salud</collab>
<source><![CDATA[Protocolos de Atención Médica. Intervenciones cubiertas por el Programa Seguro Médico para una nueva generación]]></source>
<year>2009</year>
<publisher-name><![CDATA[Secretaría de Salud]]></publisher-name>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
